𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effects of verbal reaction time in Alzheimer's disease

✍ Scribed by Ipek Midi; Müzeyyen Doǧan; Yavuz Selim Pata; Ismail Kocak; Aynur Mollahasanoglu; Nese Tuncer


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
467 KB
Volume
121
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objectives/Hypothesis:

Verbal fluency deteriorates with normal aging, but is much more severe in Alzheimer's Disease (AD). Verbal functions were analyzed to find differences between normal aging subjects in patients with mild cognitive impairment (MCI), and in patients with early and moderate stages of AD. This study measured the verbal response time in patients with AD, MCI, and in control subjects

Study Design:

This study measured the verbal response time in patients with AD, MCI, and in control subjects

Methods:

Fifteen patients with MCI, 15 patients with early AD, 8 patients with moderate AD, and 15 subjects for controls were included in the study. Word length in milliseconds, reaction time to a phoneme, word, or sentence and acoustic analysis of voice quality and speech diadochokinetic rate (DDK) were measured.

Results:

Reaction time for a phoneme, word, or sentence especially the initiation period for them were longer in patients with early AD compared to patients with MCI (P < .001). The mean DDK rate was lower with increased severity of the disease, and was much more severe in patients with moderate AD.

Conclusions:

Clinical discrimination of the early stages of AD and MCI is challenging. Unfortunately, there are no laboratory markers present for the diagnosis of preclinical cases of AD. With the results of this study, the assessments of verbal reaction time may helpful for diagnosis of early AD.


📜 SIMILAR VOLUMES


The effects of galantamine treatment on
✍ Mary Sano; Gordon K. Wilcock; Bart van Baelen; Shane Kavanagh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract ## Aim The aim of the study was to determine whether the clinical benefits of galantamine for patients with Alzheimer's disease lead to benefits for caregivers. ## Methods Data were pooled from two concurrent, multi‐centre, randomized, double‐blind, placebo‐controlled, 6‐month trials

Functional anatomy of verbal and visuosp
✍ Fabienne Collette; Eric Salmon; Martial Van der Linden; Christian Degueldre; Geo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 2 views

The aim of the study was to emphasize cerebral regions which subserve the performance of short-term memory tasks in patients with Alzheimer's disease. We correlated scores obtained on span tasks with cerebral metabolism measured at rest with positron emission tomography. Scores obtained on the digit

Risk-reducing effect of education in Alz
✍ Sigrid Botne Sando; Stacey Melquist; Ashley Cannon; Michael Hutton; Olav Sletvol 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

## Abstract ## Objective To estimate the effect of education on the risk of Alzheimer's disease (AD). ## Methods 373 patients diagnosed with AD and 559 healthy control individuals without first degree relatives with known dementia, were included in a case‐control study (2003–2006). All individua